Cansino Biologics, Inc. Class ASSE: 688185

"Cansino Biologics Inc."Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction and Semi-annual Performance Briefing

Aug 26, 2026 · Issued by Cansino Biologics, Inc. Class A via Shanghai Stock Exchange

Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction and Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Cansino Biologics, Inc. Class A

"Cansino Biologics Inc."Announcement on Abnormal Fluctuations in Stock TradingAug 22
"Cansino Biologics Inc."Announcement on Obtaining Drug Registration Certificate for Adsorbed Tetanus VaccineAug 21
"Cansino Biologics Inc."Announcement on Voluntary Disclosure of Acceptance of the Drug Registration Application for Adsorbed Tetanus, Diphtheria and Pertussis (Acellular, Five Components) Combined Vaccine (For Persons Aged 6 and Above)Aug 17
CanSino Biologics: CanSinoBIO's Menhycia® Application Accepted by China's NMPA for Expanded Use in Population Aged 3 Months to 17 YearsJul 19

All Cansino Biologics, Inc. Class A news releases